Characteristics | Total cases, N (%) |
---|---|
Age (months) | |
 < 18 | 7 (6.0) |
 ≥ 18 and < 60 | 80 (69.0) |
 ≥ 60 | 29 (25.0) |
Sex | |
 Female | 56 (48.3) |
 Male | 60 (51.7) |
Primary site | |
 Abdomen | 93 (80.2) |
 Thorax | 20 (17.2) |
 Other | 3 (2.6) |
MYCN gene | |
 Amplification | 38 (32.8) |
 Non-amplification | 78 (67.2) |
NSE (ng/ml) | |
 < 370 | 88 (75.9) |
 ≥ 370 | 28 (24.1) |
LDH (IU/L) | |
 ≤ 500 | 14 (12.1) |
 > 500 and < 1500 | 88 (75.9) |
 ≥ 1500 | 14 (12.1) |
Metastatic site | |
 Bone | 84 (72.4) |
 Bone marrow | 72 (62.1) |
 Distant lymph node | 76 (65.5) |
 Liver | 20 (17.2) |
 Central nervous system | 20 (17.2) |
Number of organs with metastasis | |
 < 3 | 59 (50.9) |
 3 | 39 (33.6) |
 > 3 | 18 (15.5) |